Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03724981 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 312
- Enrollment target
NCT03724981: Completed Phase 4 study, sponsored by Eli Lilly and Company.
NCT03724981 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 312 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03724981, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 312 participants
- Enrollment target
Study Summary
In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.
Primary Outcome
Preference of injection device was assessed by questionnaire which asks, "Overall, which device do you prefer?" The Prescott test will be run to examine if a statistically significant difference in preference between the devices exits, while controlling for order effects and taking into account the neutral responses.
Interventions
- DRUG Dulaglutide Pen
- DRUG Semaglutide Pen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2019-04-12 |
| Phase | Phase 4 |
What the finished NCT03724981 record still lists
NCT03724981 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which Dulaglutide Pen is the first listed.
NCT03724981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03724981 about?
NCT03724981 is a clinical study titled "A Study Comparing the Dulaglutide Pen and the Semaglutide Pen". In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.
What is the current status of trial NCT03724981?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 312 participants. The study started on 2018-10-18. Estimated completion is 2019-04-12.
What interventions are being tested in trial NCT03724981?
The interventions under investigation include: Dulaglutide Pen (DRUG), Semaglutide Pen (DRUG).
Who is sponsoring clinical trial NCT03724981?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03724981's enrollment target sits among peer trials
312 262nd of 2000 higher than 1,738 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI